There's a surprisingly simple reason why the US spent $3 billion on drugs that were never used
Pfizer Shrinks Its Drug Pipeline Amid R&D Cuts
The Problem with Fast-Tracking Drug Approvals: Pharmas Fail to Follow Up
More Proof That Whistleblowing on Medicaid Fraud Works
Which Sector Lost the Most Jobs in 2010? Pharma
The Top 10 Health Care Stories of 2010
WikiLeaks: Did Pfizer Use Unethical Tactics to Evade a Clinical Trial Settlement?
FDA Panel Backs Orexigen's Diet Pill
CVS to Pay $77.6 Million to Settle Charges of Selling Meth Ingredient to Criminals
Sanofi-Aventis to Cut 1,700 Jobs in the U.S.
Global Pharmaceutical Sales Expected to Rise to $880 Billion in 2011
Inside Wall Street: Achillion Is a Small Biotech on the Verge of Big Moves
Health-Care Sector Appears to Rally As Reform Chances Dim
Sanofi-Aventis Buys Chattem, a Leader in Over-the-Counter Sales
Genzyme's bad year gets worse: Experimental kidney drug a no-go
Pfizer earnings beat the Street. Beating future hurdles will be tougher
J&J, Abbott beat expectations: a good sign for pharma results yet to come?
Volunteers for clinical trials are essential -- when they enroll for the right reasons
Pfizer halts patient enrollments in a lung-cancer drug trial
Big moves in pharma today: Repros tanks, Protalix jumps
Pharma report: The good (PFE), the so-so (GSK) and the ugly (GENZ)